Aroa Biosurgery Ltd Ordinary Shares ARX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™
-
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
-
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
-
Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.
Trading Information
- Previous Close Price
- A$0.53
- Day Range
- A$0.53–0.55
- 52-Week Range
- A$0.48–0.80
- Bid/Ask
- A$0.54 / A$0.55
- Shares Outstanding
- 350.66M
- Market Cap
- A$189.36M
- Volume/Avg
- 99,347 / 268,162
Key Statistics
- Price/Earnings (Normalized)
- 46.26
- Price/Sales
- 2.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.aroa.com
Valuation
|
Metric
|
ARX
|
|---|---|
Price/Earnings (Normalized) | 46.26 |
Price/Book Value | 2.25 |
Price/Sales | 2.12 |
Price/Cash Flow | 21.88 |
Price/Earnings
ARX
Financial Strength
|
Metric
|
ARX
|
|---|---|
Quick Ratio | 3.04 |
Current Ratio | 4.77 |
Interest Coverage | 3.48 |
Quick Ratio
ARX
Profitability
|
Metric
|
ARX
|
|---|---|
Return on Assets (Normalized) | 5.68% |
Return on Equity (Normalized) | 6.75% |
Return on Invested Capital (Normalized) | 7.33% |
Return on Assets
ARX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|CgV^Z& | LOCK|N@^? | $179B | |||
| Medtronic PLC
MDT
| LOCK|zZ<mg%! | LOCK|Dzj% | $122B | |||
| Stryker Corp
SYK
| LOCK|Q?nkmc?m | LOCK|>GB | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|nQZs$Q< | LOCK|vCZ! | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|>bgY>rc@ | LOCK|t@j$l | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$L?$FP | LOCK|pq? | $32B | |||
| DexCom Inc
DXCM
| LOCK|F%Wf%&l< | LOCK|p^j&^ | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|^T | LOCK|#?> | $26B | |||
| Steris PLC
STE
| LOCK|^Wv@X< | LOCK|@%>q | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|db<>DL?l | LOCK|qc< | $19B |
United States